EMEA Midlines Catheter Market Segmentation, By Application (Oncology, Cardiovascular, Urology, Neurovascular, and Specialty), Design (Single Lumen and Double Lumen), Lumen Gauge (18 G, 20 G, 19 G, and Others), Technique (Seldinger's Technique and Ultrasonography), Age Group (Adult, Pediatric, and Geriatric), End User (Hospital, Specialty Clinic, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) - Industry Trends and Forecast to 2031
EMEA Midlines Catheter Market Analysis
The midline catheter market is experiencing significant growth due to increasing demand for minimally invasive medical procedures, particularly in chronic disease management and long-term intravenous therapy. Midline catheters offer advantages like ease of insertion, reduced infection risks, and suitability for extended use compared to traditional central venous catheters. The market is driven by the aging population, rising prevalence of diseases like cancer and diabetes, and advancements in catheter technology. Key players are focusing on product innovation and expanding their healthcare partnerships.
Midlines Catheter Market Size
EMEA midlines catheter market size was valued at USD 171.58 million in 2023 and is projected to reach USD 265.55 million by 2031, growing with a CAGR of 5.6% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Midlines Catheter Market Trends
“Increasing adoption of Midline Catheters over Traditional Intravenous (IV) Catheters”
The increasing adoption of midline catheters over traditional Intravenous (IV) catheters in the EMEA midline catheters market is primarily driven by the enhanced clinical benefits these devices offer for patients requiring extended venous access. Midline catheters, positioned in the upper arm and extending into the larger veins, provide a lower risk of complications such as phlebitis and infiltration compared to standard peripheral IV lines. Furthermore, they are suitable for therapies that span several days to weeks, allowing for longer dwell times and increased patient comfort, which is particularly advantageous in outpatient and home healthcare settings. These trends are leading healthcare providers to favor midline catheters for their efficiency and ability to improve patient outcomes, thereby catalyzing their growing market presence across EMEA.
Report Scope and Midlines Catheter Market Segmentation
|
Attributes
|
Midlines Catheter Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, and Rest of Europe, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Key Market Players
|
BD (U.S.), Teleflex Incorporated. (U.S.), Argon Medical Devices (U.S.), ICU Medical, Inc. (U.S.), Vygon (U.S.), AngioDynamics, Inc. (U.S.), Haolang Technology (Foshan) Limited Co., Ltd. (China), Deltamed (Italy), Seda S.p.A (Italy), Harsoria Healthcare Pvt Ltd (Egypt), PFM Medical, Inc. (U.S.), Medical Component Inc. (U.S.), Kimal (U.S.), Amecath (Egypt), Healthline Medical Products (U.S.), and Helmeir (India) among others
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Midlines Catheter Market Definition
A midline catheter is a type of vascular access device that is inserted into a peripheral vein, typically in the upper arm, and extends into the proximal portion of the central venous system, usually stopping just before the shoulder. Unlike traditional peripheral intravenous (IV) catheters, which are limited in terms of dwell time and suitable for short-term use, midline catheters are designed for longer-term intravenous therapy, allowing for extended infusion of medications, fluids, and nutrition over several days to weeks. They offer several advantages, including reduced risk of complications such as phlebitis and infection, increased patient comfort, and the ability to withstand higher-volume infusions, making them an essential tool in managing patients requiring ongoing treatment.
Midlines Catheter Market Dynamics
Drivers
- Rising Prevalence of Chronic Diseases
The rising prevalence of cardiovascular, renal, and neurovascular diseases has increased the demand for long-term IV therapies like medication, dialysis, and fluid management. Chronic patients frequently need venous access, but traditional central venous methods carry risks such as infections and clotting. Midline catheters offer a safer, minimally invasive alternative, staying in place for weeks and reducing the need for multiple needle insertions while lowering the risk of bloodstream infections and vein thrombosis, making them ideal for patients requiring ongoing care without central access.
For instance,
- In May 2024, according to an article published by WHO, Cardiovascular Diseases (CVDs) are the leading cause of disability and premature mortality in EMEA, accounting for over 42.5% of all annual deaths, which translates to approximately 10,000 fatalities each day. The WHO/EMEA report indicates that men in the region are nearly 2.5 times more likely to die from CVDs than women. This alarming statistic underscores the rising prevalence of chronic diseases, highlighting the urgent need for effective medical interventions. As the demand for reliable vascular access solutions like midline catheters increases in response to the growing incidence of CVDs, this trend is expected to drive the EMEA midline catheter market significantly.
The rising prevalence of chronic conditions like cardiovascular, renal, and neurovascular disorders is driving demand for midline catheters across the EMEA region. Healthcare providers are adopting these minimally invasive solutions to improve patient outcomes, reduce infections, and lower treatment costs, fueling strong market growth for reliable long-term intravenous access.
- Rising Home Healthcare Demand
The rising demand for home-based healthcare reflects a shift towards cost-effective and convenient care, particularly for patients needing long-term therapies like intravenous antibiotics or chemotherapy. Midline catheters are gaining popularity in home settings due to their ease of insertion, low complication risk, and ability to remain in place for weeks. They enable patients to self-administer medications or receive care from visiting professionals, promoting independence and reducing hospital visits. This trend supports decentralized care models in the EMEA region, positioning midline catheters as vital for safe and reliable intravenous access at home
For instance,
- In April 2024, according to an article published by BRUEGEL, the 85+ age group is the fastest-growing demographic in the EU. In 2022, 2.9% of the EU population was aged 85 or older, and this proportion is expected to more than double by 2050. This rapid growth in the oldest age group highlights the increasing healthcare needs associated with aging. As older adults require more medical care, including vascular access solutions, the demand for midline catheters is likely to rise, driving the growth of the EMEA midline catheter market.
The growing preference for home-based care and self-administration of therapies is expected to significantly boost the demand for midline catheters in the EMEA region. With their ease of use and ability to support long-term treatment, these catheters align with the shift toward patient-centered care. As healthcare providers and patients alike adopt home healthcare solutions, the EMEA midline catheter market is positioned for robust growth, driven by the need for manageable, safe, and efficient intravenous access devices outside traditional hospital settings.
Opportunity
- Increasing Demand for Vascular Access Devices
The increasing demand for vascular access devices presents significant opportunities for the midline catheter market, particularly in the EMEA region. As chronic diseases such as diabetes, cancer, and cardiovascular conditions rise, healthcare providers face a growing need for effective and reliable vascular access solutions. The shift towards minimally invasive procedures in healthcare settings further enhances the appeal of midline catheters. As healthcare professionals increasingly prioritize patient-centered care, midline catheters become a preferred choice, driving their adoption in both hospital and outpatient settings.
For instance,
- In November 2022, according to an article published by the World Health Organization for Africa region, it was estimated that 24 million adults were living with diabetes in the International Diabetes Federation (IDF) African Region. Moreover, it is projected to rise by 129% to 55 million by 2045. This projected figure infers the major usage of treatments involving vascular access solutions and midlines catheters
Therefore, the focus on patient safety and infection control is prompting healthcare providers to adopt devices with lower risks of complications. Midline catheters, known for their reduced incidence of infection and better patient outcomes, align well with this trend. As educational initiatives around the proper use and benefits of midline catheters increase, they will likely become more integrated into standard treatment protocols, further driving market growth.
Restraint/Challenge
- Increasing Availability of Alternative Therapies
The availability of alternative therapies presents a significant challenge for the EMEA midline catheters market in several ways. The rise of alternative therapies often correlates with an increased focus on patient outcomes and satisfaction. Healthcare professionals are increasingly inclined to recommend treatments that promise fewer complications and quicker recovery times. As alternative therapies, such as Peripherally Inserted Central Catheters (PICCs) or implantable ports, gain traction, midline catheters may face scrutiny regarding their efficacy and safety profiles. This necessitates a strategic response from midline catheter manufacturers, including comprehensive clinical data and real-world evidence to substantiate their product advantages.
For instance,
- In February 2024, according to an article, ‘Safety and efficacy of midline vs peripherally inserted central catheters among adults receiving IV therapy’, it was concluded that the use of midline catheters resulted in a higher incidence of catheter-related complications compared with use of peripherally inserted central catheters
- In July 2020, according to an article, ‘Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases’, it was concluded that the replacement with a central venous catheter is feasible and risk-free. Moreover, the usage is neither infectious nor thrombotic
In addition, the cost-effectiveness of alternative therapies poses a financial challenge for the midline catheter market. Budget constraints in healthcare systems across the EMEA region drive providers to seek cost-saving measures. When alternative therapies demonstrate similar or superior outcomes at a lower cost, they may be favored over midline catheters, further eroding market demand. Consequently, midline catheter producers must navigate a complex pricing environment, balancing profitability with the need to remain competitive against these alternatives.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Midlines Catheter Market Scope
The market is segmented based on application, design, lumen gauge, technique, age group, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Oncology, By Design
- Single Lumen
- Double Lumen
- Oncology, By Size
- 12-20 Cm
- 8-12 Cm
- Others
- Oncology, By Material
- Polyurethane
- Silicone
- Cardiovascular, By Design
- Single Lumen
- Double Lumen
- Cardiovascular, By Size
- 12-20 Cm
- 8-12 Cm
- Others
- Cardiovascular, By Material
- Polyurethane
- Silicone
- Urology, By Design
- Single Lumen
- Double Lumen
- Urology, By Size
- 12-20 Cm
- 8-12 Cm
- Others
- Urology, By Material
- Polyurethane
- Silicone
- Neurovascular, By Design
- Single Lumen
- Double Lumen
- Neurovascular, By Size
- 12-20 Cm
- 8-12 Cm
- Others
- Neurovascular, By Material
- Polyurethane
- Silicone
- Specialty, By Design
- Single Lumen
- Double Lumen
- Specialty, By Size
- 12-20 Cm
- 8-12 Cm
- Others
- Specialty, By Material
- Polyurethane
- Silicone
Design
- Single Lumen
- Double Lumen
Lumen Gauge
- 18 G
- 20 G
- 19 G
- Others
Technique
- Seldinger's Technique
- Ultrasonography
Age Group
- Adult
- Geriatric
- Pediatric
End User
- Hospital
- Public
- Private
- Specialty Clinic
- Ambulatory Surgical Centers
- Others
Midlines Catheter Market Regional Analysis
The market is analyzed and market size insights and trends are provided by application, design, lumen gauge, technique, age group, end user, and distribution channel as referenced above.
The countries covered in the market are Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, and rest of Europe, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.
Europe is expected to be the dominant and fastest growing region in the EMEA midlines catheter market due to its advanced healthcare infrastructure, high demand for innovative medical devices, and a strong focus on quality and patient care.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Midlines Catheter Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Midlines Catheter Market Leaders Operating in the Market Are:
- BD (U.S.)
- Teleflex Incorporated. (U.S.)
- Argon Medical Devices (U.S.)
- ICU Medical, Inc. (U.S.)
- Vygon (U.S.)
- AngioDynamics, Inc. (U.S.)
- Haolang Technology (Foshan) Limited Co., Ltd. (China)
- Deltamed (Italy)
- Seda S.p.A (Italy)
- Harsoria Healthcare Pvt Ltd (Egypt)
- PFM Medical, Inc. (U.S.)
- Medical Component Inc. (U.S.)
- Kimal (U.S.)
- Amecath (Egypt)
- Healthline Medical Products (U.S.)
- Helmeir (India)
Latest Developments in EMEA Midlines Catheter Market
- In October 2024, BD and Ypsomed are collaborating to enhance self-injection systems for high-viscosity biologics, aiming to improve patient experience and accessibility for medications requiring complex delivery methods.
SKU-